RALA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.518400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.738000E-01
Normal-vs-Stage2
4.177400E-01
Normal-vs-Stage3
8.429800E-01
Normal-vs-Stage4
2.328800E-01
Stage1-vs-Stage2
5.278600E-01
Stage1-vs-Stage3
8.581800E-01
Stage1-vs-Stage4
3.099400E-01
Stage2-vs-Stage3
4.903000E-01
Stage2-vs-Stage4
6.858600E-01
Stage3-vs-Stage4
3.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.698000E-01
Normal-vs-AfricanAmerican
5.179200E-01
Normal-vs-Asian
6.053000E-01
Caucasian-vs-AfricanAmerican
9.316800E-01
Caucasian-vs-Asian
5.254800E-01
AfricanAmerican-vs-Asian
6.678400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.926400E-01
Normal-vs-Female
3.499000E-01
Male-vs-Female
5.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.970800E-01
Normal-vs-Age(41-60Yrs)
1.540980E-01
Normal-vs-Age(61-80Yrs)
5.769200E-01
Normal-vs-Age(81-100Yrs)
5.221600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.084600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.676000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.613400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.528200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.761600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.331200E-01
Normal-vs-Daily Drinker
6.630400E-01
Normal-vs-Weekly Drinker
3.795600E-01
Normal-vs-Occasional Drinker
3.259800E-01
Normal-vs-Social Drinker
2.596400E-01
Non Drinker-vs-Daily Drinker
9.561000E-01
Non Drinker-vs-Weekly Drinker
2.848000E-01
Non Drinker-vs-Occasional Drinker
1.056020E-01
Non Drinker-vs-Social Drinker
1.058010E-01
Daily Drinker-vs-Weekly Drinker
2.990800E-01
Daily Drinker-vs-Occasional Drinker
1.080370E-01
Daily Drinker-vs-Social Drinker
1.220580E-01
Weekly Drinker-vs-Occasional Drinker
4.893800E-01
Weekly Drinker-vs-Social Drinker
6.754000E-01
Occasional Drinker-vs-Social Drinker
7.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.986200E-01
Normal-vs-Grade 2
9.221800E-01
Normal-vs-Grade 3
7.734000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.502030E-02
Grade 1-vs-Grade 3
1.911590E-02
Grade 1-vs-Grade 4
8.986200E-01
Grade 2-vs-Grade 3
7.861400E-01
Grade 2-vs-Grade 4
9.221800E-01
Grade 3-vs-Grade 4
7.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.439600E-01
Normal-vs-NonDiabetic
4.486200E-01
Diabetic-vs-NonDiabetic
3.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.480600E-01
Normal-vs-NoPancreatitis
4.688600E-01
Pancreatitis-vs-NoPancreatitis
1.871430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.762600E-01
Normal-vs-N1
3.637800E-01
N0-vs-N1
7.744400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.157800E-01
Normal-vs-TP53-NonMutant
8.700400E-01
TP53-Mutant-vs-TP53-NonMutant
1.70240999999294E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
